Hancı, FatmaTüray, SevimBayraktar, ZehraKabakuş, Nimet2021-06-232021-06-2320190883-07381708-8283https://doi.org/10.1177/0883073819865682https://hdl.handle.net/20.500.12491/9932The purpose of this study was to determine the etiologic factors, clinical characteristics, seasonal distributions, family history, response to corticosteroid therapy, recurrence and residual paralysis rates, and factors affecting these in pediatric facial palsy. Patients aged <18 years diagnosed with acute peripheral facial palsy were included in the study. Demographic data and clinical findings were retrieved from patients' records. The study was completed with 113 patients. Causes were idiopathic in 74 (65.4%) cases. Complete healing was not achieved in 6 (5.3%) patients, and recurrence was observed in 11 (9.7%). None of the patients with residual paralysis used corticosteroid, but all the patients with recurrence had employed them. We determined that young age may have an adverse impact on complication development and that corticosteroid therapy may be useful in the healing process in idiopathic facial nerve palsy. In conclusion, age may have an adverse impact in idiopathic facial nerve palsy, whereas corticosteroid therapy has a positive effect.eninfo:eu-repo/semantics/closedAccessChildhoodFacial PalsyResidueRecurrenceCorticosteroid TherapyArticle10.1177/08830738198656823414907912314076202-s2.0-85071441113Q2WOS:000482825100001Q3